Cargando…
Candesartan Does Not Activate PPARγ and Its Target Genes in Early Gestation Trophoblasts
Angiotensin II receptor 1 blockers are commonly used to treat hypertension in women of childbearing age. While the fetotoxic effects of these drugs in the second and third trimesters of pregnancy are well documented, their possible impacts on placenta development in early gestation are unknown. Cand...
Autores principales: | Neuper, Lena, Kummer, Daniel, Forstner, Désirée, Guettler, Jacqueline, Ghaffari-Tabrizi-Wizsy, Nassim, Fischer, Cornelius, Juch, Herbert, Nonn, Olivia, Gauster, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603971/ https://www.ncbi.nlm.nih.gov/pubmed/36293183 http://dx.doi.org/10.3390/ijms232012326 |
Ejemplares similares
-
Changes in Maternal Platelet Physiology during Gestation and Their Interaction with Trophoblasts
por: Forstner, Désirée, et al.
Publicado: (2021) -
Fluid shear stress induces a shift from glycolytic to amino acid pathway in human trophoblasts
por: Brugger, Beatrice Anna, et al.
Publicado: (2023) -
Placental CX3CL1 is Deregulated by Angiotensin II and Contributes to a Pro-Inflammatory Trophoblast-Monocyte Interaction
por: Nonn, Olivia, et al.
Publicado: (2019) -
Go with the Flow—Trophoblasts in Flow Culture
por: Brugger, Beatrice A., et al.
Publicado: (2020) -
Maternal Platelets—Friend or Foe of the Human Placenta?
por: Moser, Gerit, et al.
Publicado: (2019)